Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Chest MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of the International Depression Epidemiological Study across nine countries.Thorax. 2014; 69: 1090-1097
- Decreased survival in cystic fibrosis patients with a positive screen for depression.J Cyst Fibros. 2021; 20: 120-126
- Maintaining mental health and function for the long run in cystic fibrosis.Pediatr Pulmonol. 2016; 51: S71-S78
Cystic Fibrosis Foundation Patient Registry 2020 Annual Data Report Bethesda, Maryland ©2021, Cystic Fibrosis Foundation.
- Overcoming psychosocial challenges in cystic fibrosis: promoting resilience.Pediatr Pulmonol. 2018; 53: S86-S92
- Real-world safety of CFTR modulators in the treatment of cystic fibrosis: a systematic review.J Clin Med. 2021; 10: 23
- Worsening anxiety and depression after initiation of lumacaftor/ivacaftor combination therapy in adolescent females with cystic fibrosis.J Cyst Fibros. 2017; 16: 525-527
- Cystic fibrosis transmembrane regulator modulators: implications for the management of depression and anxiety in cystic fibrosis.Psychosomatics. 2017; 58: 343-354
- Trikafta and psychopathology in cystic fibrosis: a case report.Psychosomatics. 2020; 61: 735-738
- Mental health and neurocognitive side effects after initiating elexacaftor/tezacaftor/ivacaftor.J Cyst Fibros. 2021; 20S2: S130
- Mental status changes during elexacaftor/tezacaftor/ivacaftor therapy.J Cyst Fibros. 2021; 21: 339-343
- Patient perspectives following initiation of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis and advanced lung disease.Respir Med Res. 2021; 80: 100829
- Promoting emotional wellness in children with cystic fibrosis, Part I: child and family resilience.Pediatr Pulmonol. 2021; 56: S97-S106
- Diagnostic and statistical manual of mental disorders.5th edition. Author, Washington, DC2013
- The PHQ-9: validity of a brief depression severity measure.J Gen Intern Med. 2001; 16: 606-613
- A brief measure for assessing generalized anxiety disorder: the GAD-7.Arch Intern Med. 2006; 166: 1092-1097
- International Committee on mental health in cystic fibrosis: cystic fibrosis Foundation and European cystic fibrosis Society consensus statements for screening and treating depression and anxiety.Thorax. 2015; 71: 26-34
- Integration of mental health screening and treatment into cystic fibrosis clinics: evaluation of initial implementation in 84 programs across the United States.Pediatr Pulmonol. 2020; 55: 2995-3004
- Mental Health screening in cystic fibrosis centres across Europe.J Cyst Fibros. 2019; 18: 299-303
- Impact of COVID-19 on mental health: effects on screening, care delivery, and people with cystic fibrosis.J Cyst Fibros. 2021; 20: 31-38
- Promoting emotional wellness in children with CF, part II: mental health assessment and intervention.Pediatr Pulmonol. 2021; 56: S107-S122
- The Preschool Pediatric Symptom Checklist (PPSC): development and initial validation of a new social/emotional screening instrument.Acad Pediatr. 2012; 12: 456-467
- Pediatric Symptom Checklist: screening school-age children for psychosocial dysfunction.J Pediatr. 1988; 112: 201-209
- The PSC-17: Subscale Scores, reliability, and factor structure in a new national sample.Pediatrics. 2016; 138: e20160038
- Understanding needle-related distress in children with cystic fibrosis.Br J Health Psychol. 2011; 16: 329-343
- Review: adult outcome as seen through controlled prospective Follow-up studies of children with attention-deficit/hyperactivity disorder followed into adulthood.J Am Acad Child Adolesc Psychiatry. 2021; 61: 378-391
- Sleep disturbance and psychiatric disorders.Lancet Psychiatry. 2020; 7: 628-637
- International classification of sleep disorders.3rd edition. Author, Darien, IL2014
- Sleep disturbances and their impact in pediatric cystic fibrosis.Sleep Med Rev. 2018; 42: 100-110
- Sleep findings and predictors of sleep desaturation in adult cystic fibrosis patients.Sleep Breath. 2012; 16: 1041-1048
- Comorbidity studies of eating disorders and mood disorders. Critical review of the literature.J affective Disord. 2007; 97: 37-49
- Disordered eating and body image in cystic fibrosis. Diet and exercise in cystic fibrosis.Academic Press, San Diego (CA)2015: 11-18
- Eating disorders and diabetes.Curr Diabetes Rep. 2020; 20: 32
- The large spectrum of pulmonary complications following illicit drug use: features and mechanisms.Chem Biol Interact. 2013; 206: 444-451
- Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.Arch Gen Psychiatry. 2004; 61: 807-816
- Self-reported alcohol use in the cystic fibrosis community.J Cyst Fibros. 2020; 19: 84-90
- Use of medical marijuana in cystic fibrosis patients.BMC Complement Med therapies. 2020; 20: 323
- Chronic opioid use and clinical outcomes in lung transplant recipients: a single-center cohort study.Clin Respir J. 2018; 12: 2446-2453
- National trends of hospitalizations in cystic fibrosis highlight a need for pediatric to adult transition clinics.Pancreas. 2021; 50: 704-709
- ECFS best practice guidelines: the 2018 revision.J Cyst Fibros. 2018; 17: 153-178
- Cystic fibrosis standards of care, Australia.North Ryde, Sydney, NSW2008
- Preventing depression and anxiety: results of a pilot study of a CF-specific CBT intervention for adults with CF.Pediatr Pulmonol. 2019; 54: 397
- Psychological interventions during COVID pandemic: telehealth for individuals with cystic fibrosis and caregivers.Pediatr Pulmonol. 2021; 56: 1976-1984
- Pilot RCT of a telehealth intervention to reduce symptoms of depression and anxiety in adults with cystic fibrosis.J Cyst Fibros. 2022; 21: 332-338
- ACT with CF: a telehealth and in-person feasibility study to address anxiety and depressive symptoms among people with cystic fibrosis.J Cyst Fibros. 2021; 20: 133-139
- Psychological therapies for anxiety and depression in children and adolescents with long-term physical conditions.Cochrane Database Syst Rev. 2018; 12: Cd012488
- Update on the use of SSRIs and SNRIs with children and adolescents in clinical practice.J Can Acad Child Adolesc Psychiatry. 2016; 25: 4-10
- Georgiopoulos A, Friedman D, Sher Y. Best practice guide: Management of depression and anxiety Improving Life with CF: A Primary Palliative Care Partnership 2021.(Available at:) (Accessed October 28, 2021)
- Therapeutic challenges posed by critical drug-drug interactions in cystic fibrosis.Pediatr Pulmonol. 2016; 51: S61-S70
Vertex Pharmaceuticals. Trikafta prescribing information. 2019. https://pi.vrtx.com/files/uspi_elexacaftor_tezacaftor_ivacaftor.pdf. Accessed February 6, 2022.
- The demographics of adverse outcomes in cystic fibrosis.Pediatr Pulmonol. 2019; 54 Suppl 3: S74-S83
- Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study.Am J Prev Med. 1998; 14: 245-258
- Children's Comfort Promise; successfully implementing an evidence based pain protocol for needle procedures throughout a large children's hospital and clinic system.J Pain. 2016; 17: S43
- Parent management training and problem-solving skills training for child and adolescent conduct problems.in: Weisz J.R. Kazdin A.E. Evidence-based psychotherapies for children and adolescents. 3rd edition. Guilford Press, New York2017: 142-158
- Treatment and intervention services for autism Spectrum disorder.2019 (Available at:) (Accessed October 28, 2021)
- A meta-analysis on the treatment effectiveness of cognitive behavioral therapy for primary insomnia.Sleep Biol Rhythms. 2011; 9: 24-34
- Randomized noninferiority trial of telehealth delivery of cognitive behavioral treatment of insomnia compared to in-person care.J Clin Psychiatry. 2021; 82: 20m13723
- Cognitive and behavioural therapy for insomnia (CBT-I) in psychiatric populations: a systematic review.Int Rev Psychiatry (Abingdon, England). 2014; 26: 205-213
- Adverse respiratory events associated with hypnotics use in patients of chronic obstructive pulmonary disease: a population-based case-control study.Medicine. 2015; 94: e1110
- Eating disorders in primary care: diagnosis and management.Am Fam Physician. 2021; 103: 22-32
- A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders.J Subst Abuse Treat. 2008; 34: 123-138
- Effective treatments for opioid addiction.(Available at:) (Accessed October 28, 2021)
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
